Approval · Notice of Compliance 18026 · 2016
IPG-EZETIMIBE: Notice of Compliance 18026
Issued April 26, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18026
- Date
- April 26, 2016
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Merger - buyout
- Canadian reference product
- EZETROL (Merck Frosst)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IPG-EZETIMIBE | 02421119 | Approved |
Medicinal ingredients
- EZETIMIBE 10 MG per TAB